Biogen, UCB reportedly showing interest in Acorda acquisition; Kite Pharma and Pfizer to develop combo lymphoma therapy; hospitals to form generics nonprofit
Five things for pharma marketers to know: Thursday, January 18, 2018
Senate committee votes in favor of Azar as new HHS head; FDA and DoD launch breakthrough designation program; Walmart offers free opioid disposal solution
Why Greater Than One’s Elizabeth Apelles stands firm on independence
Celgene reportedly in talks to buy Juno; Novartis’ Kymriah receives fast-track reviews in U.S. and Europe; BI’s Gilotrif gets expanded approval in lung cancer
McCann Health promotes Marcus Sigurdsson to global chief digital officer
Merck’s Keytruda combo therapy succeeds in Phase-III lung cancer trial; FDA launches pilot to address trial transparency; Spark’s Luxturna overpriced, ICER says
Five things for pharma marketers to know: Friday, January 12, 2018